These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36835839)

  • 21. Qualitative and Quantitative Assessment of Vascular Changes in Diabetic Macular Edema after Dexamethasone Implant Using Optical Coherence Tomography Angiography.
    Toto L; D'Aloisio R; Di Nicola M; Di Martino G; Di Staso S; Ciancaglini M; Tognetto D; Mastropasqua L
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
    Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
    BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intravitreal dexamethasone implant in treatment-naive and previously-treated patients with diabetic macular edema.
    Nikolopoulou E; Sacconi R; Lorusso M; Costanzo E; Parravano M; Micelli Ferrari L; Ferrari TM; Querques G
    Eur J Ophthalmol; 2022 Dec; ():11206721221143166. PubMed ID: 36457210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macular vessels density in diabetic retinopathy: quantitative assessment using optical coherence tomography angiography.
    AttaAllah HR; Mohamed AAM; Ali MA
    Int Ophthalmol; 2019 Aug; 39(8):1845-1859. PubMed ID: 30194547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-cube 30° × 25° optical coherence tomography in diabetic macular edema.
    Mahdjoubi A; Bousnina Y; Bendib FS; Bensmaine F; Idlefqih W; Chahed S; Ghezzaz A
    Int J Retina Vitreous; 2021 Mar; 7(1):19. PubMed ID: 33676574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography.
    Hunt M; Teper S; Wylęgała A; Wylęgała E
    J Diabetes Res; 2022; 2022():3547461. PubMed ID: 35237693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-life outcomes of intravitreal ranibizumab, aflibercept, and dexamethasone implant administrations in patients with treatment-naïve diabetic macular edema.
    Korkmaz A; Karti O; Zengin MO; Yuksel B; Kusbeci T
    Saudi J Ophthalmol; 2022; 36(3):327-334. PubMed ID: 36276250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optical Coherence Tomography Biomarkers of Inflammation in Diabetic Macular Edema Treated by Fluocinolone Acetonide Intravitreal Drug-Delivery System Implant.
    Arrigo A; Capone L; Lattanzio R; Aragona E; Zollet P; Bandello F
    Ophthalmol Ther; 2020 Dec; 9(4):971-980. PubMed ID: 32914324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Appearance of cysts and capillary non perfusion areas in diabetic macular edema using two different OCTA devices.
    Parravano M; Costanzo E; Borrelli E; Sacconi R; Virgili G; Sadda SR; Scarinci F; Varano M; Bandello F; Querques G
    Sci Rep; 2020 Jan; 10(1):800. PubMed ID: 31964977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OCT-Based Biomarkers are Associated with Systemic Inflammation in Patients with Treatment-Naïve Diabetic Macular Edema.
    Zhou J; Song S; Zhang Y; Jin K; Ye J
    Ophthalmol Ther; 2022 Dec; 11(6):2153-2167. PubMed ID: 36166152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
    Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Implications of Suspended Scattering Particles in Motion Observed by Optical Coherence Tomography Angiography.
    Ahn J; Han S; Ahn SM; Kim SW; Oh J
    Sci Rep; 2020 Jan; 10(1):15. PubMed ID: 31913306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optical Coherence Tomography Parameters Related to Vision Impairment in Patients with Diabetic Macular Edema: A Quantitative Correlation Analysis.
    Li B; Zhang B; Chen Y; Li D
    J Ophthalmol; 2020; 2020():5639284. PubMed ID: 33062313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 36. Profile of non-responder and late responder patients treated for diabetic macular edema: systemic and ocular factors.
    Parravano M; Costanzo E; Querques G
    Acta Diabetol; 2020 Aug; 57(8):911-921. PubMed ID: 32114642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinal ultrastructural, electrophysiological, and microvascular morphological outcomes in diabetic macular edema treated with intravitreal bevacizumab.
    Gulyesil FF; Inan S; Gobeka HH; Sabaner MC; Alizada A
    Ir J Med Sci; 2023 Feb; 192(1):149-159. PubMed ID: 35322868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OCT-Angiography Changes in Patients with Diabetic Macular Edema Treated with Intravitreal Dexamethasone Implant.
    Carnota-Méndez P; Méndez-Vázquez C; Pérez-Gavela C
    Clin Ophthalmol; 2022; 16():247-263. PubMed ID: 35140455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of macular vascular density and foveal avascular zone changes by optical coherence tomography angiography (OCT-A) after intravitreal dexamethasone implant in diabetic macular edema resistant to Anti-VEGF treatment.
    Ceylan A; Dogan ME; Demircan A; Akar Y
    Int Ophthalmol; 2022 Nov; 42(11):3579-3588. PubMed ID: 35737210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome.
    Vadalà M; Sunseri Trapani V; Guarrasi G; Ventura N; Castellucci M; Cillino S
    Clin Ophthalmol; 2020; 14():2657-2665. PubMed ID: 32982158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.